Agilon Health Inc Stock Price, News & Analysis

agilon health (NYSE: AGL), a company focused on empowering physicians to transform healthcare, has announced its plans to release second quarter 2024 financial results. The results will be disclosed after the market closes on Tuesday, August 6, 2024, followed by a conference call at 4:30 PM Eastern Time to discuss the outcomes. Interested parties can access the call via phone or webcast, with details provided for both U.S. and international participants. A replay of the call will be made available on the company's Investor Relations website for on-demand listening after the event concludes.

agilon health announced the appointment of Karthik Rao, M.D., as its permanent Chief Medical Officer (CMO), effective immediately. Dr. Rao has been serving as interim CMO since February 2024 and was previously senior medical director and vice president of network performance at agilon. With nearly a decade of experience as a practicing internal medicine physician, Dr. Rao will co-lead clinical strategy and oversee clinical programs alongside Chief Clinical Officer Kevin Spencer, M.D., who brings over 25 years of experience in value-based care. Both will report to CEO Steve Sell and aim to enhance provider performance across agilon's Physician Network.

agilon health (NYSE: AGL) has appointed Jeff Schwaneke as its new Chief Financial Officer (CFO) and Executive Vice President, effective July 1, 2024. Schwaneke, who brings over 27 years of finance and operational experience, will transition from his current role as Executive Vice President at Centene He will succeed Timothy Bensley, who is retiring but will assist during the transition. Schwaneke will step down from agilon’s board, where he has served since 2022. His extensive background includes significant roles at Centene, where he contributed to revenue growth from $20 billion to $125 billion. Schwaneke holds a Bachelor's degree in Accounting from the University of Missouri and is a CPA (inactive).

agilon health (NYSE: AGL) will participate in the 44th Annual William Blair Growth Stock Conference with a presentation scheduled on June 5 at 12:20 PM Eastern Time. Interested parties can access a live webcast via the “Events & Presentations” section of agilon’s Investor Relations website, with a replay available for on-demand listening after the event.

Agilon health reported strong financial and operational results for the first quarter of 2024, with revenue increasing by 52% to $1.6 billion and Medicare Advantage membership growing by 43% to 523,000. The company continues to focus on driving profitability and enhancing operating efficiency while maintaining its full-year guidance for Medical Margin and Adjusted EBITDA. Agilon health is making progress on its performance action plan to improve performance and support growth in Adjusted EBITDA in 2024 and beyond. The company also announced new partnerships with leading physician groups, expanding its presence in several states. With a solid capital position and positive outlook for the fiscal year, agilon health is poised for continued success.

agilon health (AGL) has announced new physician partnerships with five leading practices to transition to a full-risk, value-based care model. This expansion will include over 3,000 primary care physicians reaching 700,000 senior patients in 30+ communities. The partnerships will enhance the quality of care for senior patients and further agilon's mission of transforming healthcare delivery.